Integrated Eye Tracking and Neural Monitoring for TBI: Optimization
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03451058 |
|
Recruitment Status :
Completed
First Posted : March 1, 2018
Last Update Posted : February 11, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Traumatic Brain Injury |
This study (N=100) will be a correlational study to assess cognitive function in healthy controls, individuals with mild TBI, and individuals with moderate-to-severe TBI.
In general, participants will provide demographic information, medical history, and details of their head injury. Participants will also complete a brief neuropsychological assessment to obtain an index of cognitive ability, along with the Fusion Test with eye tracking and linked EEG. MRI data may also be obtained.
| Study Type : | Observational |
| Actual Enrollment : | 138 participants |
| Observational Model: | Cohort |
| Time Perspective: | Cross-Sectional |
| Official Title: | Integrated Eye Tracking and Neural Monitoring for Enhanced Assessment of Mild TBI: Clinical Optimization Study |
| Actual Study Start Date : | July 7, 2017 |
| Actual Primary Completion Date : | December 31, 2021 |
| Actual Study Completion Date : | December 31, 2021 |
| Group/Cohort |
|---|
|
Mild TBI Group
History of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
|
|
Moderate to Severe TBI Group
History of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
|
|
Healthy Controls
No history of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
|
- EEG [ Time Frame: One study visit ]Spectral features and event related responses collected from scalp measurements during performance of an eye movement and working memory task.
- Eye Tracking [ Time Frame: One study visit ]Saccadic latencies measured in response to cognitive task including working memory demands.
- Neurobehavioral Symptom Inventory (NSI) [ Time Frame: One study visit ]Self-report measure of post-concussive symptoms
- Trail Making Test [ Time Frame: One study visit ]Consists of Part A and B which depends on psychomotor speed, visual search abilities, and placing demands on working memory and cognitive flexibility
- Symbol Search [ Time Frame: One study visit ]Wechsler Adult Intelligence Scale- Fourth Edition (WAIS-IV) Symbol Search measures information processing speed
- Digit Span [ Time Frame: One study visit ]WAIS-IV Digit Span including Digit Span Forward, Digit Span Backward, and Digit Span Sequencing, which measures memory span.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
All groups:
- Ability to use dominant hand to complete cognitive and motor tasks
- Fluent in English
Mild TBI group:
- History of mild TBI > 3 months and < 10 years prior to enrollment
- Self-report of post-concussive symptoms
Moderate-to-Severe TBI group:
- History of moderate or severe TBI > 3 months and < 10 years prior to enrollment
Exclusion Criteria:
Control group:
History of possible or confirmed brain injury
All groups:
- History of a medical condition (other than brain injury) that would be expected to affect cognitive or motor abilities (e.g. muscular dystrophy, multiple sclerosis, or psychotic disorders such as schizophrenia)
- Presence of neurological condition, such as brain tumor, brain infection, seizure, or stroke
- Presence of visual impairment that is uncorrected by glasses or contacts (including color blindness)
- Evidence of current suicidal or homicidal ideation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03451058
| United States, California | |
| Naval Medical Center San Diego | |
| San Diego, California, United States, 92134 | |
| Responsible Party: | Lynita Mullins, Department Head, Physical Medicine and Rehabilitation, United States Naval Medical Center, San Diego |
| ClinicalTrials.gov Identifier: | NCT03451058 |
| Other Study ID Numbers: |
NMCSD.2017.0012 |
| First Posted: | March 1, 2018 Key Record Dates |
| Last Update Posted: | February 11, 2022 |
| Last Verified: | February 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Traumatic brain injury, eye tracking, EEG, cognition |
|
Brain Injuries Brain Injuries, Traumatic Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries |

